Found: 53
Select item for more details and to access through your institution.
Absence of Grail promotes CD8<sup>+</sup> T cell anti-tumour activity.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00252-w
- By:
- Publication type:
- Article
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. 89, doi. 10.1016/j.clml.2021.08.005
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 99, doi. 10.1016/j.clml.2012.11.002
- By:
- Publication type:
- Article
The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 15, doi. 10.1016/j.clml.2012.09.009
- By:
- Publication type:
- Article
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficient Modulation of T-cell Response by Dual-mode, Single-carrier Delivery of Cytokine-targeted siRNA and DNA Vaccine to Antigen-presenting Cells.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 12, p. 2011, doi. 10.1038/mt.2008.206
- By:
- Publication type:
- Article
Rush Hour Traffic: Directing T Cells to Tumor.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Rush hour traffic: directing T cells to tumor.
- Published in:
- 2014
- By:
- Publication type:
- editorial
Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 3, p. 253, doi. 10.1038/6995
- By:
- Publication type:
- Article
Verapamil synergistically enhances cytotoxicity of bortezomib in mantle cell lymphoma via induction of reactive oxygen species production.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 2, p. 243, doi. 10.1111/bjh.12003
- By:
- Publication type:
- Article
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 2, p. 284, doi. 10.1111/j.1365-2141.2011.08618.x
- By:
- Publication type:
- Article
Targeting cell surface β.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 1, p. 111, doi. 10.1111/j.1365-2141.2011.08714.x
- By:
- Publication type:
- Article
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 1, p. 47, doi. 10.1111/j.1365-2141.2010.08315.x
- By:
- Publication type:
- Article
Bone Marrow Stromal Cells Derived MCP-1 Reverses the Inhibitory Effects of Multiple Myeloma Cells on Osteoclastogenesis by Upregulating the RANK Expression.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082453
- By:
- Publication type:
- Article
Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 670, doi. 10.1111/bjh.15814
- By:
- Publication type:
- Article
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 80, doi. 10.1111/bjh.13796
- By:
- Publication type:
- Article
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 726, doi. 10.1111/bjh.13659
- By:
- Publication type:
- Article
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 463, doi. 10.1111/bjh.13603
- By:
- Publication type:
- Article
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 509, doi. 10.1111/bjh.13628
- By:
- Publication type:
- Article
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 814, doi. 10.1111/bjh.13367
- By:
- Publication type:
- Article
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 5, p. 689, doi. 10.1111/bjh.13349
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 207, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
Prospective phase II study of rituximab with alternating cycles of hyper- CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 611, doi. 10.1111/bjh.12585
- By:
- Publication type:
- Article
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 1, p. 138, doi. 10.1111/bjh.12326
- By:
- Publication type:
- Article
A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.
- Published in:
- Journal of Translational Medicine, 2004, v. 2, p. 9, doi. 10.1186/1479-5876-2-9
- By:
- Publication type:
- Article
Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry.
- Published in:
- Proteomics, 2004, v. 4, n. 4, p. 1195, doi. 10.1002/pmic.200300677
- By:
- Publication type:
- Article
B-cell malignancies as a model for cancer vaccines: from prototype protein to next generation genetic chemokine fusions.
- Published in:
- Immunological Reviews, 1999, v. 170, n. 1, p. 115, doi. 10.1111/j.1600-065X.1999.tb01333.x
- By:
- Publication type:
- Article
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens.
- Published in:
- International Immunology, 2000, v. 12, n. 5, p. 691, doi. 10.1093/intimm/12.5.691
- By:
- Publication type:
- Article
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 2 Trial of Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus Methotrexate- Cytarabine for Relapsed or Refractory Aggressive Mantle Cell Lymphoma.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 10, p. 2734, doi. 10.1002/cncr.23880
- By:
- Publication type:
- Article
The changing investment in translational science by academic medical centers: HOPE in the Valley of Death.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.
- Published in:
- Journal of Clinical Investigation, 2004, v. 113, n. 10, p. 1498, doi. 10.1172/JCI200420312
- By:
- Publication type:
- Article
Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50880-2
- By:
- Publication type:
- Article
Translational development of active immunotherapy for hematologic malignancies.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Prime-Boost Vaccination Using Chemokine-Fused gp120 DNA and HIV Envelope Peptides Activates Both Immediate and Long-Term Memory Cellular Responses in Rhesus Macaques.
- Published in:
- Journal of Biomedicine & Biotechnology, 2010, p. 1, doi. 10.1155/2010/860160
- By:
- Publication type:
- Article
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2139, doi. 10.1007/s00262-020-02614-8
- By:
- Publication type:
- Article
Targeting myeloid-derived suppressor cells for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1181, doi. 10.1007/s00262-018-2175-3
- By:
- Publication type:
- Article
Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Corrigendum to "Prime-Boost Vaccination Using Chemokine-Fused gp120 DNA and HIV Envelope Peptides Activates Both Immediate and Long-Term Memory Cellular Responses in Rhesus Macaques".
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/5471638
- By:
- Publication type:
- Article
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice.
- Published in:
- Nature Medicine, 2014, v. 20, n. 6, p. 676, doi. 10.1038/nm.3560
- By:
- Publication type:
- Article
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Designer cancer vaccines are still in fashion.
- Published in:
- Nature Medicine, 2000, v. 6, n. 9, p. 966, doi. 10.1038/79649
- By:
- Publication type:
- Article
Complete molecular remissions induced by patient-specific vaccination plus granulocyte?monocyte colony-stimulating factor against lymphoma.
- Published in:
- Nature Medicine, 1999, v. 5, n. 10, p. 1171, doi. 10.1038/13928
- By:
- Publication type:
- Article
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0631-3
- By:
- Publication type:
- Article
MACOP-B +/- radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford results according to prognostic indices.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Clinical significance of morphologic subdivision in diffuse large cell lymphoma.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Dose-Related Safety and Immunogenicity of Baculovirus-Expressed Trivalent Influenza Vaccine: A Double-Blind, Controlled Trial in Adult Patients with Non-Hodgkin B Cell Lymphoma.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 10, p. 1394, doi. 10.1086/508493
- By:
- Publication type:
- Article